A number of hormones and neurohormones have been shown to exert their effect on their target tissues by altering the intracellular level of 3'5'-cyelic AM\IP.1 Among the processes mediated by cyclic AMP is the secretion of macromolecules by various endocrine and exocrine glands. Incubation procedure: The incubation medium was Tyrode solution containing 5 mM glutamine and 100 gg/ml crystalline soybean trypsin inhibitor. Female albino Swiss mice weighing 20-30 gm were used. Mice that had fasted for 36-48 hr were killed by decapitation, and the whole pancreas was removed. Each pancreas was preincubated for 15 min in 10 ml of medium gassed with 95% 02 + 5% CO2. To start the incubation, a single pancreas was transferred to 3.0 ml of medium containing the appropriate additions in a stoppered 25-ml Erlenmeyer flask equipped with an inlet and outlet tube for gassing. The flasks were gassed for 1 min with 95% 02 + 5% CO2. Both preincubation and incubation were carried out at 370 in a rotatory shaking water bath (New Brunswick Scientific Co., Inc.) at 120 rpm. The incubation time was 60 min. At the end of the incubation, the pancreas was removed from the medium and homogenized with 5.0 ml of 0.03 M phosphate buffer, pH 6.9, containing 7 mM NaCl. Amylase in the medium and in the homogenate was determined immediately after the incubation was terminated.
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Other details of the procedure were as described previously. In most experiments, a considerable amount of amylase was released into the medium in the absence of added stimulants. Since the release of amylase by the control was inhibited by DNP, it seemed to be due to active secretion evoked by an endogenous stimulant. Secretion stimulated by pancreozymin was also inhibited by DNP, which confirms that it is an active process. Further evidence that the release of amylase in the presence of secretory stimulants is an active process selective for digestive enzymes comes from the observation that the specific activity of the amylase in the medium after secretion was several times higher than that of the amylase extracted from the pancreas. Table 2 shows that atropine, a cholinergic blocking agent, inhibited secretion stimulated by carbamyl choline but did not appreciably affect secretion stimulated by pancreozymin, peptavlon, or epinephrine. Inderal, an adrenergic blocking agent,'2 inhibited secretion stimulated by epinephrine but had no effect on secretion stimulated by pancreozymin, peptavlon, or carbamyl choline.
Effects of theophylline, 3'5'-cyclic AMP, and its mono-and dibutyryl derivatives on secretion: Free cyclic AMP as well as its mono-and dibutyryl derivatives"s stimulated secretion (Table 3) . Monobutyryl cyclic AMP usually stimulated slightly more strongly than free cyclic AMP or the dibutyryl derivative. Theophylline, an inhibitor of the phosphodiesterase that hydrolyzes cyclic AMP,14 5 X 10-7 M; peptavlon, 0.5 jug/ml; pancreozymin, 2 X 10-2 Crick units/ml; epinephrine, 10-4 M (two additions of 10-4 M as in Table 1 ); inderal, 2 X 10-4 M; atropine, 10-4 M, except with epinephrine as stimulant when 2 X 10-4 M was added.
Pancreases were preincubated with inhibitors for 5 min before additon of stimulants.
also stimulated secretion. DNP inhibited secretion resulting from the presence of theophylline, cyclic AMP, or its butyryl derivatives, which indicates that the process was an active one requiring energy from oxidative phosphorylation. As was found with other secretory stimulants, the specific activity of amylase in the medium at the end of secretion was much higher than that of amylase extracted from the pancreas. Inhibition of secretion by 3'-AMP: Secretion stimulated by cyclic AMP was inhibited by 3'-AMP but not by 5'-AMP (Table 3) . As in the case of DNP, 3'-AMP inhibited secretion below that of the control, which indicates that endogenous secretion was also inhibited by this nucleotide. The data presented in Table 4 indicate a competitive relationship between 3'-AMP and cyclic AMP. 3'-AMP also inhibited secretion stimulated by pancreozymin, peptavlon, and carbamyl choline (Table 5) . Although 3'-AMP strongly inhibited secretion caused by the latter secretory stimulants, its inhibitory effect was less complete than with cyclic AMP as stimulant.
Discussion.-The data presented show that enzyme secretion by mouse pancreas can be activated by pancreozymin, peptavlon, carbamyl choline, and catecholamines. Both cholinergic agents and pancreozymin have been previously shown to stimulate secretion by the pancreas in vitro. 8' 11, 15, 16 Gastrin The following concentrations were used: theophylline, 10 mM; DNP, 1 mM; cyclic AMP, 1 mM; monobutyryl cyclic AMP, 1 mM; dibutyryl cyclic AMP 1 mM; 3'-AMP, 10 mM; 5'-AMP, 10 mM. VOL. 61, 1968 Cyclic AMP (1 mM) 13 Cyclic AMP (10 mM) 12 Cyclic AMP (1 mM) + 3'-AMP (2 mM) 4 Cyclic AMP (10 mM) + 3'-AMP (2 mM) 11 Cyclic AMP (1 mM) + 3'-AMP (10 mM) 2 Cyclic AMP (10 mM) + 3'-AMP (10 mM) 5 and gastrin analogues have been shown in other laboratories to stimulate pancreatic secretion in VzVo.6, 17, 18 However, we are not aware of experiments other than ours that show stimulation of secretion of isolated pancreas by gastrin analogues and thus confirm their direct action on the pancreas. Because of the high concentrations of catecholamines required for stimulation of secretion, and because of the variable effects of these agents, the physiological significance of our observations on their action remains obscure.
The question arises whether the different stimulants all act directly on the exocrine pancreas cells or whether only some act directly and mediate the action of the others. Recent studies show that the amino acid sequence at the Cterminal end of pancreozymin closely resembles or is identical with the sequence of the C-terminal tetrapeptide of peptavlon.'9 It is thus likely that pancreozymin and peptavlon act on the same receptor site. Since neither adrenergic nor cholinergic blocking agents inhibit the stimulation of secretion by peptavlon and pancreozymin, it seems reasonable to conclude that these hormones act directly on the exocrine pancreas and not via the release of endogenous acetylcholine or catecholamines. The failure of inderal to inhibit the secretion stimulated by carbamyl choline indicates that its effect is not mediated by endogenous catecholamines, which have been shown to play an important role in secretion by the parotid.'0 Since no specific inhibitors of the action of peptavlon or pancreozymin are available, it was not possible to conclude whether carbamyl choline acts directly on the exocrine pancreas cells or by releasing endogenous pancreozymin or gastrin.
The observation that secretion by mouse pancreas is stimulated by cyclic AM\iP and its butyryl derivatives strongly suggests that cyclic AMP acts as an intracellular activator of secretion. Further support for the involvement of cyclic AMP in pancreatic secretion comes from the finding that theophylline, a specific inhibitor of the phosphodiesterase that hydrolyzes cyclic AMP,'14 Carbamyl choline 30 11
The following concentrations were used: pancreozymin, 2 X 10-2 Crick units/ml; peptavlon, 0.5 ;pg/ml; carbamyl choline, 5 X 10-7 M; 3'-AMP, 10 mM. In vessels where 3'-AMP was added, pancreases were preincubated with the inhibitor for 5 min before the addition of stimulants.
stimulates secretion. It is of interest that free cyclic AMP is almost as active as its mono-and dibutyryl derivatives in stimulating secretion in the mouse pancreas, since many of the tissues whose activities are mediated by cyclic A1IP do not respond to the addition of the free nucleotide.J Although the stimulatory effect of cyclic AMP indicates that it plays a role in the activation of secretion in the mouse pancreas, it does not show whether cyclic A1\iP is a necessary intermediate in the action of pancreozymin, peptavlon, or carbamyl choline. Evidence suggesting that cyclic AMP mediates the activity of all three stimulants comes from the action of 3'-AMP. It has been shown in the present work that 3'-AMP is a potent inhibitor of secretion and that it inhibits secretion induced by cyclic AMP in a competitive manner. The most plausible explanation of these observations is that 3'-AMP inhibits by competition for the receptor site to which cyclic AMP must bind in order to activate secretion. If this interpretation of the data is correct, then the observation that 3'-AMP inhibits secretion stimulated by pancreozymin, peptavlon, and carbamyl choline favors the conclusion that the stimulatory action of all three substances involves the formation of cyclic AMP.
The data are consistent with the hypothesis that the peptide hormones pancreozymin and peptavlon act directly on the adenyl cyclase of the exocrine pancreas. It is less clear, however, from the results presented whether carbamyl choline acts on adenyl cyclase. Cholinergic agents have previously been shown to inhibit the formation of cyclic AMP in cardiac tissue,2' but to our knowledge there is no information in the literature to show whether there are any tissues in which cholinergic substances can increase the accumulation of cyclic AMP.
In conclusion, it seems worthwhile to discuss some implications of the inhibitory effect of 3'-AMIP. The evidence presented above strongly supports the view that in the mouse pancreas, 3'-AMP acts as a competitive inhibitor on the receptor site for cyclic AMP. The question arises whether 3'-AMP is also a cyclic AMP antagonist in other systems. Rall and Sutherland22 found that a mixture of 2'-and 3'-AMP did not inhibit the stimulatory effect of cyclic AMP on the formation of active phosphorylase in extracts of dog liver. However, the maximum concentration of 2'-and 3'-AMP (3 X 10-4 M) used by these investigators was lower than the concentration of 3'AMP (10-3 M) found to be inhibitory in the present investigation. In a recent paper, evidence was presented that several purine nucleosides act as inhibitors on the cyclic AMP receptor site of adipose tissue.23 If 3'-AMP and purine nucleosides prove to be cyclic AMP antagonists in systems other than those so far tested, they could serve as powerful diagnostic tools to detect the participation of cyclic AMP in various biological processes. Moreover, such antagonists may be valuable for characterizing the receptor site of cyclic AMP, which in most systems is still an unknown entity.
Summary.-Secretion of amylase by isolated mouse pancreas was stimulated by pancreozymin, peptavlon (a synthetic gastrin-like pentapeptide), carbamyl choline, and to a lesser extent, by catecholamines. Theophylline, 3'5'-cyclic AMP, and its mono-and dibutyryl derivatives were also potent stimulators of secretion. 3'-AMP inhibited secretion induced by cyclic AMP in a competitive manner. These observations are interpreted to mean that 3'-AMP binds to the receptor site for cyclic AMP in the secretory apparatus. Since 3'-AMP also inhibited secretion stimulated by pancreozymin, peptavlon, and carbamyl choline, it is probable that all these stimulants induce secretion via formation of cyclic AMP.
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